The use of adalimumab in the management of Crohn's disease: Scottish society of gastroenterology audit 2007

被引：0
|
作者：
Ho, G.
Smith, L.
Aitken, S.
Lee, H.
Ting, D.
Fennell, J.
Lees, C.
Palmer, K.
Penman, I.
Shand, A.
Arnott, I.
Priest, M.
Boulton-Jones, R. [1 ]
Russell, R.
Mowat, C. [2 ]
Wilson, D. [3 ]
Satsangi, J.
机构：
[1] Yorkhill Hosp, Gastrointestinal Unit, Glasgow, Lanark, Scotland
[2] Ninewells Hosp, Gastrointestinal Unit, Dundee, Scotland
[3] Royal Hosp Sick Childrens, Gastrointestinal Unit, Dundee, Scotland
来源：
GUT | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
001
引用
收藏
页码：A1 / A1
页数：1
相关论文
共 50 条
  • [1] The use of adalimumab in the management of refractory Crohn's disease
    Ho, G. -T.
    Smith, L.
    Aitken, S.
    Lee, H. M.
    Ting, T.
    Fennell, J.
    Lees, C. W.
    Palmer, K. R.
    Penman, I. D.
    Shand, A. G.
    Arnott, I. D.
    Satsangi, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (04) : 308 - 315
  • [2] Management of Crohn's disease in poor responders to adalimumab
    de Boer, Nanne K. H.
    Lowenberg, Mark
    Hoentjen, Frank
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 : 83 - 92
  • [3] Management of Crohn's disease of the ileal pouch with adalimumab
    Li, Yue
    Lopez, Rocio
    Queener, Elaine
    Shen, Bo
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S42 - S43
  • [4] Guidelines for the management of patients with Crohn's disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
    Lodyga, Michal
    Eder, Piotr
    Gawron-Kiszka, Magdalena
    Dobrowolska, Agnieszka
    Gonciarz, Maciej
    Hartleb, Marek
    Klopocka, Maria
    Malecka-Wojciesko, Ewa
    Radwan, Piotr
    Regula, Jaroslaw
    Zagorowicz, Edyta
    Rydzewska, Grazyna
    GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2021, 16 (04): : 257 - 296
  • [5] Adalimumab for Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (04): : 291 - 291
  • [6] Adalimumab in Crohn's disease
    Van Assche, Gert
    Vermeire, Severine
    Rutgeerts, Paul
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (04): : 355 - 365
  • [7] Adalimumab - In Crohn's disease
    Plosker, Greg L.
    Lyseng-Williamson, Katherine A.
    BIODRUGS, 2007, 21 (02) : 125 - 132
  • [8] Guidelines for the management of Crohn's disease. Recommendations of the Working Group of the Polish National Consultant in Gastroenterology and the Polish Society of Gastroenterology
    Lodyga, Michal
    Eder, Piotr
    Bartnik, Witold
    Gonciarz, Maciej
    Klopocka, Maria
    Linke, Krzysztof
    Malecka-Panas, Ewa
    Radwan, Piotr
    Regula, Jaroslaw
    Rydzewska, Grazyna
    PRZEGLAD GASTROENTEROLOGICZNY, 2012, 7 (06): : 317 - 338
  • [9] Indian Society of Gastroenterology consensus statements on Crohn’s disease in India
    Ramakrishna B.S.
    Makharia G.K.
    Ahuja V.
    Ghoshal U.C.
    Jayanthi V.
    Perakath B.
    Abraham P.
    Bhasin D.K.
    Bhatia S.J.
    Choudhuri G.
    Dadhich S.
    Desai D.
    Goswami B.D.
    Issar S.K.
    Jain A.K.
    Kochhar R.
    Loganathan G.
    Misra S.P.
    Ganesh Pai C.
    Pal S.
    Philip M.
    Pulimood A.
    Puri A.S.
    Ray G.
    Singh S.P.
    Sood A.
    Subramanian V.
    Indian Journal of Gastroenterology, 2015, 34 (1) : 3 - 22
  • [10] Successful use of adalimumab (Humira) for Crohn's disease in pregnancy
    Mishkin, Daniel S.
    Van Deinse, William
    Becker, James M.
    Farraye, Francis A.
    INFLAMMATORY BOWEL DISEASES, 2006, 12 (08) : 827 - 828
12345